20 Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...


Gainers

  • Sunedison Semiconductor Ltd SEMI rose 42.5 percent to $11.80 in pre-market trading as GlobalWafers Co., Ltd. agreed to buy SunEdison Semiconductor for US$12.00 per share in cash. Citigroup upgraded SunEdison Semiconductor from Sell to Neutral.
  • Cobalt International Energy, Inc. CIE shares rose 23.8 percent to $1.30 in pre-market trading after gaining 5.99 percent on Wednesday.
  • Raptor Pharmaceutical Corp. RPTP shares rose 15.8 percent to $7.99 in pre-market trading. Retrophin Inc RTRX is considering an acquisition of Raptor Pharmaceutical, according to Bloomberg.
  • Immunomedics, Inc. IMMU shares rose 9.4 percent to $3.14 in pre-market trading after the company reported that its preclinical study on enhancing IMMU-132 activity in SN-38-resistant cancer cells increased the median survival of mice.
  • SCYNEXIS Inc SCYX rose 8.9 percent to $2.82 in pre-market trading after surging 25.73 percent on Wednesday.
  • NetApp Inc. NTAP rose 8.3 percent to $31.25 in pre-market trading as the company reported better-than-expected earnings for its fiscal first quarter on Wednesday.
  • Canadian Solar Inc. CSIQ rose 8.1 percent to $13.20 in the pre-market trading session. Canadian Solar reported Q2 earnings of $0.68 per share on revenue of $805.9 million.
  • Arrowhead Pharmaceuticals Inc ARWR rose 6.8 percent to $6.77. Cantor Fitzgerald initiated coverage on Arrowhead Pharmaceuticals with a Buy rating.
  • Staples, Inc. SPLS rose 6.3 percent to $9.22 in pre-market trading after dropping 7.07 percent on Wednesday.
  • L Brands Inc LB rose 4 percent to $77.00 in pre-market trading as the company posted upbeat earnings for its second quarter after market close on Wednesday.
  • Wal-Mart Stores, Inc. WMT rose 3.4 percent to $75.40 in pre-market trading as the company reported better-than-expected EPS and revenue for the second quarter. The company updated its EPS forecast for the full year.
  • YY Inc (ADR) YY rose 3.3 percent to $50.70 in the pre-market trading session. YY reported a Q2 profit of $51.7 million and reported the resignation of Chairman Mr. Jun Lei.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Cerulean Pharma Inc CERU fell 61.3 percent to $1.06 in pre-market trading after the company reported failed CRLX101/Avastin trial results. Leerink Swann, Janney Capital and JMP Securities downgraded the stock following the news.
  • Portola Pharmaceuticals Inc PTLA shares fell 15.6 percent to $19.99 in pre-market trading as the company reported that it has received a CRL from the FDA for Biologics License Application for AndexXa.
  • Juniper Pharmaceuticals Inc JNP shares dropped 15.3 percent to $6.03 in pre-market trading. Juniper Pharma reported that its Phase 2b trial of COL-1077 lidocaine vaginal gel did not meet primary and secondary endpoints.
  • Aerie Pharmaceuticals Inc AERI shares fell 14.8 percent to $16 in pre-market trading.
  • Oncomed Pharmaceuticals Inc OMED shares fell 14 percent to $10.07 in pre-market trading. OncoMed priced an offering of 5.5 million shares at $10 per share.
  • Momo Inc (ADR) MOMO fell 4.5 percent to $14.88 in pre-market trading. Momo reported Q2 adjusted earnings of $0.03 per ADS and announced that the Buyer Group will withdraw the non-binding go-private offer.
  • Agilent Technologies Inc A shares fell 4 percent to $46.49 in the pre-market trading session. Agilent posted better-than-expected earnings for its third quarter. However, the company reported downbeat quarterly sales and issued a weak FY16 guidance.
  • Twitter Inc TWTR shares fell 2.5 percent to $19.67 in pre-market trading. Evercore ISI Group downgraded Twitter from Hold to Sell and lowered the price target from $18.00 to $17.00.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket GainersLosersTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...